The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Siemens Healthineers' Versant HCV Genotype 2.0 Assay (LiPA) to detect Hepatitis C virus (HCV).

The simple, standardised assay is designed to identify and detect genotype and subtype of HCV.

Featuring a fully automated strip processing, the assay is claimed to improve lab efficiency and accuracy with an integrated system from nucleic acid extraction and amplification to interpretation.

"These products, which include the world’s most widely used HCV genotyping assay, will guide physicians in planning the most effective method of antiviral therapy for patients with Hepatitis C infections."

Siemens Healthineers molecular diagnostics head Fernando Beils said: “The FDA’s approval of our Versant HCV Genotype 2.0 Assay (LiPA), along with last year’s introduction of Versant kPCR Sample Prep at AACC, exemplifies Siemens Healthineers’ commitment to-and excitement about -molecular diagnostics in the US.

“These products, which include the world’s most widely used HCV genotyping assay, will guide physicians in planning the most effective method of antiviral therapy for patients with Hepatitis C infections.”

The assay identifies the six genotypes as well as subtypes 1a and 1b, while the HCV core region inclusion enables precise differentiation of subtypes 1a and 1b, in addition to determination of genotype 6.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It also includes a simple, single-step RT-PCR kit that can be utilised on commonly available thermocyclers for easy use and enhanced laboratory efficiency.

The assay acts as an important tool to determine therapies for patients, as the existing treatment regimens are not effective on all HCV genotypes, and an assessment of HCV genotype, subtypes 1a or 1b is necessary.